Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone

Br J Haematol. 2012 May;157(4):411. doi: 10.1111/j.1365-2141.2012.09088.x. Epub 2012 Mar 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Boronic Acids / administration & dosage
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Plasma Cell / complications*
  • Neoplasms, Plasma Cell / drug therapy
  • Pyrazines / administration & dosage
  • Pyrazines / therapeutic use*
  • Scleromyxedema / drug therapy*
  • Scleromyxedema / etiology*
  • Scleromyxedema / pathology
  • Thalidomide / administration & dosage
  • Thalidomide / therapeutic use*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Thalidomide
  • Bortezomib
  • Dexamethasone